GLP-1 Market
LLY $1123.00 ▼ -0.1% NVO $44.01 ▼ -1.2% PFE $27.65 ▼ -0.5% VKTX $32.13 ▼ -1.7% KLRA $14.91 ▲ +0.5% GPCR $39.55 ▼ -4.1% RHHBY $53.19 ▼ -0.4% HIMS $27.44 ▼ -1.6% WW $14.78 ▼ -1.1%
Delayed · As of 9:20 AM

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

ROSE-010 150 mcg

Company
Rose Pharma Inc
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
None currently listed

Efficacy results: Not yet reported

No recruiting studies currently listed

See all studies for this drug

Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026

Trial details
  • Completed NCT NCT01056107

    Effects of ROSE-010 on GI Transit in Constipation Predominant Irritable Bowel Syndrome (C-IBS) Patients

    Not yet reported, Not yet reported Mayo Clinic 52 participants Est. completion 2011-12 1 site Stand-alone
    Other conditions: Irritable Bowel Syndrome Constipation Predominant
    View official trial listing →
  • Completed NCT NCT02731664

    GLP-1 Inhibits Prandial Antro-duodeno-jejunal Motility in Humans

    Not yet reported Uppsala University 12 participants Est. completion 2017-08 1 site
    Other conditions: Functional Gastrointestinal Disorders
    View official trial listing →
  • Completed NCT NCT06621017

    Effect of GLP-1 Analogue ROSE-010 on Appetite in Overweight and Obese Subjects

    Not yet reported Rose Pharma Inc 40 participants Est. completion 2025-02-27 1 site Stand-alone
    Other conditions: Obesity; Overweight
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: ROSE-010 150 mcg, ROSE-010, ROSE-010 99 mcg

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.